High-capacity 'gutless' adenoviral vectors

Current Opinion in Molecular Therapeutics

Volumn 3, Issue 5, 2001, Pages 454-463

  Kochanek, S ^a   Schiedner, G ^a   Volpers, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenovirus; Gene transfer vector; Gutless vectors; Helper dependent adenovirus vector; High capacity adenovirus vector

Indexed keywords

DNA; GENE PRODUCT; RECOMBINANT ALPHA INTERFERON; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA INTEGRATION; DNA TRANSFER; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION; GENE TRANSFER; GENETIC ORGANIZATION; GENETIC TRANSDUCTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOGENICITY; LIVER; MOUSE; MUSCLE; NONHUMAN; TOXICITY; VIRUS CAPSID; VIRUS GENE; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CAPSID; CENTRAL NERVOUS SYSTEM; DNA, RECOMBINANT; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC TECHNIQUES; GENETIC VECTORS; GENOME, VIRAL; HUMANS; LIVER; MICE; MUSCLE, SKELETAL; VIRUS INTEGRATION;

ADENOVIRIDAE; ANIMALIA; HEPATITIS C VIRUS; MIRIDAE; MURINAE;

EID: 0034782151     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Expanded-capacity adenoviral vectors - The helper-dependent vectors
2. High-capacity adenoviral vectors for gene transfer and somatic gene therapy
3. Improvements in adenoviral vector technology: Overcoming barriers for gene therapy
4. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus
5. Development of a FLP/frt system for generating helper-dependent adenoviral vectors
6. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination
7. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector
8. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors
9. System for efficient helper-dependent minimal adenovirus construction and rescue
10. Optimization of the helper-dependent adenovirus system for production and potency in vivo
11. Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector
12. Frequency and stability of chromosomal integration of adenovirus vectors
13. Retargeting of high-capacity adenoviral vectors
14. A capsid-modified adenovirus vector devoid of all viral genes: Assessment of transduction and toxicity in human hematopoietic cells
15. Sustained high-level expression of full-length human Factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector
16. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor
17. Liver-specific α2 interferon gene expression results in protection from induced hepatitis
18. An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus
19. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector
20. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
21. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle
22. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector
23. Helper-dependent adenovirus vectors: Their use as a gene delivery system to neurons
24. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic gene therapy for chronic diseases
25. Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors
26. Helper-dependent adenoviral vector-mediated gene transfer in aged rat brain